Home/SarcoMed USA/Ira N. Kalfus
IN

Ira N. Kalfus

Chief Medical Officer

SarcoMed USA

SarcoMed USA Pipeline

DrugIndicationPhase
SM001 (alidornase/Tigerase)Pulmonary SarcoidosisPre-clinical
No-alpha IL-2 MuteinCancerPre-clinical